Cargando…

UV exposure and melanoma prognostic factors : results from Clinical National Melanoma Registry (CNMR)

Detalles Bibliográficos
Autores principales:	Montella, Maurizio, Gandini, Sara, Rossi, Carlo Riccardo, Testori, Alessandro, Mastrangelo, Giuseppe, Serraino, Diego, Budroni, Mario, Crispo, Anna, Grimaldi, Antonio Maria, Ascierto, Paolo Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108857/ http://dx.doi.org/10.1186/1479-5876-12-S1-P3

Ejemplares similares

The surgical treatment of non-metastatic melanoma in a Clinical National Melanoma Registry Study Group (CNMR): a retrospective cohort quality improvement study to reduce the morbidity rates
por: Vecchiato, Antonella, et al.
Publicado: (2021)

Real Life Clinical Management and Survival in Advanced Cutaneous Melanoma: The Italian Clinical National Melanoma Registry Experience
por: Crispo, Anna, et al.
Publicado: (2021)

Sun exposure and melanoma prognostic factors
por: GANDINI, SARA, et al.
Publicado: (2016)

Report from the second MIB (Melanoma Independent Board) Conference, 27–28 October 2014
por: Testori, Alessandro, et al.
Publicado: (2015)

Superficial and deep lymph node dissection for stage III cutaneous melanoma: clinical outcome and prognostic factors
por: Mozzillo, Nicola, et al.
Publicado: (2013)

Report from the Melanoma Independent Board First Melanoma MIB Conference, 21–22 October 2013
por: Testori, A, et al.
Publicado: (2014)

The role of BRAF V600 mutation in melanoma
por: Ascierto, Paolo A, et al.
Publicado: (2012)

Editorial: Combination Strategies in the Treatment of Melanoma
por: Ascierto, Paolo Antonio
Publicado: (2016)

The dose-response relationship between tobacco smoking and the risk of lymphomas: a case-control study
por: Taborelli, Martina, et al.
Publicado: (2017)

Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy
por: Casula, Milena, et al.
Publicado: (2009)

Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use
por: Ascierto, Paolo A, et al.
Publicado: (2012)

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
por: Morello, Silvana, et al.
Publicado: (2017)

Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy
por: Ascierto, Maria Libera, et al.
Publicado: (2015)

Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management
por: Simeone, Ester, et al.
Publicado: (2019)

Dendritic cell-derived exosomes (Dex) are potential biomarkers of response to Ipilimumab in metastatic melanoma
por: Stucci, Stefania, et al.
Publicado: (2015)

Immunotherapy in non-melanoma skin cancer: updates and new perspectives
por: Ascierto, Paolo Antonio, et al.
Publicado: (2019)

The role of spectrophotometry in the diagnosis of melanoma
por: Ascierto, Paolo A, et al.
Publicado: (2010)

Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment Registry
por: Rauwerdink, Daan Jan Willem, et al.
Publicado: (2022)

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

Efficacy and safety of ipilimumab in elderly patients with pretreated advanced melanoma treated at Italian centres through the expanded access programme
por: Chiarion Sileni, Vanna, et al.
Publicado: (2014)

Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
por: Grimaldi, Antonio Maria, et al.
Publicado: (2015)

Anorectal and Genital Mucosal Melanoma: Diagnostic Challenges, Current Knowledge and Therapeutic Opportunities of Rare Melanomas
por: Ottaviano, Margaret, et al.
Publicado: (2022)

Surgical management of melanoma: an EORTC Melanoma Group survey
por: Testori, A, et al.
Publicado: (2013)

Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: a case-control study in Italy
por: Taborelli, Martina, et al.
Publicado: (2016)

Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2006)

MicroRNAs in melanoma development and resistance to target therapy
por: Fattore, Luigi, et al.
Publicado: (2017)

Correlation between BRAF mutational status and clinical response to pembrolizumab in advanced melanoma patients
por: Simeone, Ester, et al.
Publicado: (2015)

Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients
por: Tallerico, Rossana, et al.
Publicado: (2015)

Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study
por: Montella, Maurizio, et al.
Publicado: (2015)

Main roads to melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2009)

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”, Napoli, December 5th-8th 2013
por: Ascierto, Paolo A, et al.
Publicado: (2014)

The cost of unresectable stage III or stage IV melanoma in Italy
por: Maio, Michele, et al.
Publicado: (2012)

The great debate at “Melanoma Bridge 2018”, Naples, December 1st, 2018
por: Ascierto, Paolo A., et al.
Publicado: (2019)

NF-κB as potential target in the treatment of melanoma
por: Madonna, Gabriele, et al.
Publicado: (2012)

COVID-19 in melanoma patients: Results of the Spanish Melanoma Group Registry, GRAVID study
por: Gonzalez-Cao, Maria, et al.
Publicado: (2021)

Mortality Trend for Tumor Correlated Immune System in Hyperendemic Area of HCV Infection in Southern Italy: Joinpoint Analysis
por: Montella, Maurizio, et al.
Publicado: (2013)

Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned
por: Trojaniello, Claudia, et al.
Publicado: (2023)

Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib
por: Queirolo, Paola, et al.
Publicado: (2016)

The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019
por: Ascierto, Paolo A., et al.
Publicado: (2020)

What’s new in melanoma? Combination!
por: Ascierto, Paolo A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fsi8c8pktdi59dglm7cjh0hnsd